BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1136 related articles for article (PubMed ID: 25658461)

  • 1. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.
    Dakhlallah D; Zhang J; Yu L; Marsh CB; Angelos MG; Khan M
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):241-51. PubMed ID: 25658461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.
    Chen Y; Zhao Y; Chen W; Xie L; Zhao ZA; Yang J; Chen Y; Lei W; Shen Z
    Stem Cell Res Ther; 2017 Nov; 8(1):268. PubMed ID: 29178928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-206 is involved in survival of hypoxia preconditioned mesenchymal stem cells through targeting Pim-1 kinase.
    Zhang Y; Lei W; Yan W; Li X; Wang X; Zhao Z; Hui J; Shen Z; Yang J
    Stem Cell Res Ther; 2016 Apr; 7(1):61. PubMed ID: 27103465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
    Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
    Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous miRNA-146a Enhances the Therapeutic Efficacy of Human Mesenchymal Stem Cells by Increasing Vascular Endothelial Growth Factor Secretion in the Ischemia/Reperfusion-Injured Heart.
    Seo HH; Lee SY; Lee CY; Kim R; Kim P; Oh S; Lee H; Lee MY; Kim J; Kim LK; Hwang KC; Chang W
    J Vasc Res; 2017; 54(2):100-108. PubMed ID: 28407626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway.
    Chen JJ; Zhou SH
    Cardiol J; 2011; 18(6):675-81. PubMed ID: 22113756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interleukin-7 in fusion of rat bone marrow mesenchymal stem cells with cardiomyocytes in vitro and improvement of cardiac function in vivo.
    Haneef K; Ali A; Khan I; Naeem N; Jamall S; Salim A
    Cardiovasc Ther; 2018 Dec; 36(6):e12479. PubMed ID: 30451388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of myocardial transplantation of mesenchymal stem cells transfected with vascular endothelial factor gene on improvement of heart function and angiogenesis after myocardial infarction: experiment with rats].
    Yang JF; Zhou WW; Tang T; Yu JF; Zhou XM; Hu JG
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(15):1027-34. PubMed ID: 16784704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia.
    Liu CB; Huang H; Sun P; Ma SZ; Liu AH; Xue J; Fu JH; Liang YQ; Liu B; Wu DY; Lü SH; Zhang XZ
    Stem Cells Transl Med; 2016 Aug; 5(8):1004-13. PubMed ID: 27334487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of mesenchymal stem cells overexpressing IL10 attenuates cardiac impairments in rats with myocardial infarction.
    Meng X; Li J; Yu M; Yang J; Zheng M; Zhang J; Sun C; Liang H; Liu L
    J Cell Physiol; 2018 Jan; 233(1):587-595. PubMed ID: 28322445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart.
    Glass C; Singla DK
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2038-49. PubMed ID: 21856911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair.
    Zhang Z; Yang J; Yan W; Li Y; Shen Z; Asahara T
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-23a is involved in tumor necrosis factor-α induced apoptosis in mesenchymal stem cells and myocardial infarction.
    Mao J; Lv Z; Zhuang Y
    Exp Mol Pathol; 2014 Aug; 97(1):23-30. PubMed ID: 24269648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction.
    Bostjancic E; Zidar N; Stajer D; Glavac D
    Cardiology; 2010; 115(3):163-9. PubMed ID: 20029200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mi R -15a/15b Cluster Modulates Survival of Mesenchymal Stem Cells to Improve Its Therapeutic Efficacy of Myocardial Infarction.
    Tu Y; Qiu Y; Liu L; Huang T; Tang H; Liu Y; Guo W; Jiang H; Fan Y; Yu B
    J Am Heart Assoc; 2019 Jan; 8(1):e010157. PubMed ID: 30616426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
    Huang J; Zhang Z; Guo J; Ni A; Deb A; Zhang L; Mirotsou M; Pratt RE; Dzau VJ
    Circ Res; 2010 Jun; 106(11):1753-62. PubMed ID: 20378860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
    Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J
    Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.